A total of 34% of the patients with wild-type PIK3CA tumors and 33% of the patients with a tumor mutation in the PIK3CA gene took aspirin regularly after the diagnosis of colorectal cancer. This evidence concerns the gene PIK3CA and colorectal cancer.